Philips Visual Patient Avatar Pioneers At-a-Glance Patient Data for Faster, Better Decision-Making in the Operating Room

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of Visual Patient Avatar, a revolutionary new monitoring solution that translates critical, yet complex patient data into a straightforward visual design as an easy-to-understand avatar display.

In today's operating rooms (ORs), time constraints and information overload contribute to poor situational awareness, which is responsible for 81.5% of anesthesia-related errors [1]. In the past, monitors in the OR told the patient's story by displaying vital signs and numbers that took time to interpret, potentially affecting the caregiver’s ability to absorb information and make timely clinical decisions. Visual Patient Avatar is designed to improve situational awareness with ground-breaking elegance by visualizing vital information through animations, colors and shapes. By glancing at a monitor with Visual Patient Avatar, anesthesiologists and nurse anesthetists can recall and process critical data more quickly, efficiently and confidently - ultimately helping to save lives. This new view has the potential to provide clinical teams with the peace of mind to concentrate on what matters most and prepare for what may come next.

A uniquely inspired design to improve situational awareness

Visual Patient Avatar was designed in partnership with two clinicians at the Visualization Technology Research Group at the Institute of Anesthesiology, University Hospital of Zürich. The inspiration for Visual Patient Avatar came from a hobby of the two clinicians, flying airplanes. During flights, an airplane’s dashboard uses synthetic vision technology to share straightforward illustrations that mirror flight environments. This visual representation of what is going on around them has been found to help pilots confidently make flight-related decisions. The clinicians saw the benefit of deploying a similar visual approach to patient monitors, believing that presenting data and information in a simple, visual way that has a logical commonality to the patient could help reduce human error in the OR.

"Created by anesthesiologists for anesthesiologists and nurse anesthetists, the intentionally simple design of Visual Patient Avatar is having a profound impact on clinical confidence and addressing cognitive overload," said Christoph Pedain, General Manager, Hospital Patient Monitoring at Philips. "By helping clinical care teams make timely decisions without losing their cognitive focus, they can prepare for what may come next - improving patient outcomes and saving lives."

Proven results in the real-world setting

The launch of Visual Patient Avatar is the latest example of Philips’ long-standing commitment to providing clinicians with reliable clinical decision support. To ensure the design of the Visual Patient Avatar would provide clinicians with the support they need in their daily roles, Philips and University Hospital of Zürich together conducted studies with over 150 clinicians in two Swiss hospitals to validate and refine Visual Patient Avatar using a range of proven methods. Key findings include:
  • Compared to the identical conventional monitoring scenarios, Visual Patient Avatar more than doubled the number of vital signs participants could recall after 3- and 10-second looks at the monitor. [2]
  • Visual Patient Avatar increased the percentage of perceived vital signs by 57% when viewed for 10 seconds, and the perceived workload for the task decreased by 12%. [3]
  • During the first use of Visual Patient Avatar, 73% of all vital sign information was correctly identified. [4]

"Both flying planes and caring for patients involve continuous evaluation of critical parameters in high-stakes environments," agreed David Tscholl, MD and Christoph Nöthiger, MD, consulting Anesthesiologists at University Hospital of Zürich. "As licensed pilots and anesthesiologists, we know the impact that situational awareness has on the successful outcome of our tasks and the safety of those who are affected by our work. In the air and in the OR. We had a vision to simplify the way critical information is presented in clinical settings and working with Philips to help bring this vision to life is sure to help revolutionize care."

Visual Patient Avatar will be available as an option on select IntelliVue patient monitors in 185 countries. For more information on Philips Visual Patient Avatar, please visit www.philips.com/visual-patient-avatar.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries.

1. Schulz et al. BMCA. 2016, Anesthesiology. 2017.
2. MC Anesthesiol. 2016;16(14) doi: 10.1186/s12871-016-0172-7 2 Tscholl DW, Handschin L, Neubauer P, et al. Using an animated patient avatar to improve perception of vital sign information by anesthesia professionals. British Journal of Anaesthesia. 2018;121(3):662-671. doi: 10.1016/j.bja.2018.04.024
3. Garot O, Rossler J, Pfarr J, et al. Avatar-based versus conventional vital sign display in a central monitor for monitoring multiple patients: a multicenter computer-based laboratory study. BMC Medical Informatics and Decision Making.2020;20(26). doi.org/10.1186/s12911-020-1032-4
4. 6 Wetli DJ, Bergauer L, Nothiger CB, et al. Improving Visual-Patient-Avatar Design Prior to Its Clinical Release: A Mixed Qualitative and Quantitative Study. Diagnostics (Basel). 2022;12(2):555.5. doi.org/10.3390/diagnostics12020555

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...